Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges
Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges have?
Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges has 266 citations in the OpenAlex counts ScholarIQ stores.
When was Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges published?
Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges has 2022 year in the ScholarIQ index.
What is the open-access status of Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges?
Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges has gold oa status in the ScholarIQ index.
What is the DOI of Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges?
The DOI for Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges is on the source record.
What is the PMID of Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges?
The PMID for Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges is on the source record.
What is the OpenAlex record for Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges?
The OpenAlex for Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges is on the source record.